Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameTata Health
Stock Code01255
Company Full NameTo be extracted
Industry消费零售
Principal Activities在香港、台湾及澳门分销及零售多个国际品牌的时尚舒适鞋类产品,包括Clarks、Josef Seibel、The Flexx及Yokono
Listing Date2013-07-11
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港新界葵涌葵德街15-33號葵德工業中心2座11樓F-J室
Business Address (Hong Kong)香港新界葵涌葵德街15 – 33號葵德工業中心2座11樓F – J室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websites-culture.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 2.13 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 0.01 / shares
Offer Period2013-06-28 to 2013-07-04
Global Offering Shares50,000,000 shares
HK Public Offer Shares (Initial)5,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)45,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO200,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 106,500,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 461.3M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +2006%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利约25.1百万港元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 HKD
Income Statement
Item 201020112012
Revenue 365,846472,443505,289
Cost of sales -148,508-175,910-178,326
Gross profit 217,338296,533326,963
Other income and gains, net 446378626
Selling and distribution expenses -111,056-152,553-188,144
Administrative expenses -82,019-105,631-104,880
Operating profit 23,73239,25731,869
Net finance costs -1,508-1,666-1,747
Profit before tax 22,22437,59130,122
Income tax expense -4,139-6,089-5,043
Profit for the year 18,08531,50225,079
Profit attributable to owners 18,08531,50225,079
Balance Sheet
Item 201020112012
Cash and cash equivalents 19,47132,44828,028
Trade and bills receivables 54,57258,68467,013
Inventories 90,53794,517125,852
Total current assets 186,140193,741222,523
Total assets 240,966265,625294,625
Total current liabilities 121,965125,497129,593
Total liabilities 140,007141,497144,953
Total equity 100,959124,128149,672
Equity attributable to owners 100,959124,128149,672
Interest-bearing borrowings 54,96667,66693,057
Cash Flow Statement
Item 201020112012
Net cash from operating activities 49,76312,874-15,857
Net cash from investing activities -40,714-523-5,719
Net cash from financing activities 4271,03216,941
Net increase in cash 9,47613,383-4,635
Depreciation of PP&E 5,9977,53010,760
Purchase of PP&E -31,057-14,745-12,196
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 2.13
First Day OpenHK$ 2.23
First Day Change-10.80%
First Day Volume19300000.0
First Day Turnover41877900.0
Use of Proceeds
1、約1280萬港元,即所得款項凈額約17.1%將用作在中國開設新零售店; 2、約1930萬港元,即所得款項凈額約25.7%將用作在香港及臺灣開設新零售店; 3、約2300萬港元,即所得款項凈額約30.7%將用作償付應付現有股東的尚未支付金額及應付直接控股公司款項; 4、約600萬港元,即所得款項凈額約8.0%將用作翻新我們于香港及臺灣的零售店; 5、約380萬港元,即所得款項凈額約5.0%將用作提升我們的信息科技系統; 6、約380萬港元,即所得款項凈額約5.0%將用作重整我們在香港及臺灣的物流設施; 7、約380萬元港幣,即所得款項凈額約5.0%將用作營銷及推廣; 8、余額約250萬港元,即所得款項凈額3.5%將用作額外營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
RHB Capital Hong Kong Limited CE AGC194
Overall Coordinators (1)
RHB SECURITIES HONG KONG LIMITED CE ADU220
Joint Bookrunners (1)
RHB SECURITIES HONG KONG LIMITED CE ADU220
Joint Lead Managers (1)
RHB SECURITIES HONG KONG LIMITED CE ADU220

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman楊軍—
Company Secretary周永恒—
No director data available.

Major Shareholders

Major Shareholders & HoldingsKTS International持有51.17%,Chung Nam Fashion持有20.47%;莊學山先生透过受控法团间接持有73.04%
About this page

This page shows Tata Health (01255) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect